Can digital tools better track disability in a rare nerve disease? a new study aims to find out.
NCT ID NCT06968975
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This observational study follows about 200 people in the United States who have chronic inflammatory demyelinating polyneuropathy (CIDP) and still experience disability despite at least three months of standard treatment. Researchers will track changes in disability scores and explore digital biomarkers over one to two years. The goal is to better understand real-world outcomes and how treatment changes affect daily function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify better ways to measure disability and treatment response in CIDP, potentially guiding future care.
- What could go wrong
- As an observational study, it cannot prove cause and effect. Results may be influenced by differences in patient care and data collection across sites.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site
RECRUITINGSwiftwater, Pennsylvania, 18370-0187, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.